ADJUVANT COMBINATIONS COMPRISING AN NKT ACTIVATOR, A CD40 AGONIST, AND OPTIONALLY AN ANTIGEN AND USE THEREOF FOR INDUCING A SYNERGISTIC ENHANCEMENT IN CELLULAR IMMUNITY

摘要

Adjuvant combinations comprising at least one NKT activator, such as alph a-galactosylceramide (.alpha.-Gal-Cer) or iGb3, a CD40 agonist and optionall y an antigen are disclosed. The use of these immune adjuvants for treatment of various chronic diseases such as cancers is also provided.